Mr Neill Patani, Consultant Oncoplastic & Reconstructive Breast Surgeon

Mr Neill Patani BSc (Hons) MBBS (Hons) PhD FRCS

Consultant Oncoplastic & Reconstructive Breast Surgeon

BSc (Hons) MBBS (Hons) PhD FRCS

Areas of expertise

  • Breast pain
  • Breast lumps
  • Nipple problems
  • Skin changes
  • Lymph glands

Address

  • The Princess Grace Hospital (Mon, Wed, Fri: 09:00-17:00)

    42-52 Nottingham Place, London, W1U 5NY

  • The London Breast Institute (Mon, Wed, Fri: 09:00-17:00)

    The Princess Grace Hospital, 42-52 Nottingham Place, Marylebone, London, W1U 5NY

  • Telephone or video consultation

    Virtual

About Mr Neill Patani

GMC number: 6078267

Year qualified: 2003

Place of primary qualification: University of London

Mr Neill Patani is a Consultant Oncoplastic Breast Surgeon (UCLH), Honorary Associate Professor (UCL) and Postdoctoral Research Fellow (Francis Crick Institute). Mr Patani’s private practice is based exclusively at HCA Healthcare UK's, London Breast Institute, at the Princess Grace Hospital, where he provides specialist breast care, that is evidence-based and patient-centered.

Neill has expertise in the management of breast cancer and all aspects of benign disease, including breast pain, lumps, infection and risk-reduction strategies for patients with a family history. He has a particular interest in extending the scope of breast conserving surgery with oncoplastic techniques and de-escalation of breast and axillary surgery after neo-adjuvant therapy. Neill has experience with a range of breast reconstruction techniques, including nipple-sparing approaches and one-stage pre-pectoral implant reconstruction. He works closely with plastic surgeons for natural tissue reconstruction where possible.

Mr Patani has an academic interest in laboratory, translational and clinical breast cancer research and has received prestigious grants and funding from the Wolfson Foundation, Cancer Research UK and Medical Research Council. He was awarded 1st Class Honours for his BSc in Tumour Biology at UCL and completed his PhD in Breast Cancer at the Royal Marsden Hospital and Institute of Cancer Research. Working collaboratively with scientists, oncologists and radiologists, Neill is currently exploring how breast cancer metabolism can be targeted for functional imaging and novel therapies. He is also involved in clinical trials studying the optimal sequencing of breast cancer treatments and the de-escalation of surgery following neo-adjuvant therapy.

Neill plays an active role in teaching and training. He is currently Educational Lead for the Breast Service at UCLH, and previously a Faculty Member of the Royal College of Surgeons of England and National Representative at the Oncoplastic Breast Surgery Training Interface Group. He was a Surgical Teaching Fellow for Imperial College & Anatomy Demonstrator at UCL Medical School.

Areas of expertise

  • Abscess
  • Acellular dermal matrix
  • Armpit lump
  • Axillary clearance
  • Benign breast disease
  • Benign conditions
  • Breast cancer
  • Breast consultation
  • Breast health & wellness
  • Breast lump excision
  • Breast pain
  • Breast reconstruction
  • Nipple-sparing techniques & one-stage pre-pectoral implants with acellular dermal matrix
  • Cysts
  • De-escalation of breast and axillary surgery according to treatment response
  • De-escalation of surgery according to treatment response
  • Ductal carcinoma in situ (DCIS)
  • Excision of lymph nodes
  • Extending the scope of breast conserving surgery
  • Family history
  • Fibroadenoma
  • Health check
  • Implant problems
  • Implant reconstruction
  • Infection
  • Laboratory, translational and clinical breast cancer research
  • Lipo-modelling
  • Lumps
  • Lymph glands
  • Malignant breast disease
  • Mammoplasty
  • Mastalgia (breast pain)
  • Mastectomy
  • Mastitis
  • Neoadjuvant therapy
  • Nipple discharge
  • Nipple problems
  • Nipple reconstruction
  • Nipple surgery
  • Nipple-sparing mastectomy
  • Oncoplastic surgery
  • Oncoplastic techniques, including therapeutic mammoplasty
  • One-stage pre-pectoral implants with acellular dermal matrix
  • Optimal sequencing of breast cancer treatments according to tumour biology
  • Sentinel lymph node biopsy and targeted axillary dissection after neo-adjuvant therapy
  • Skin changes
  • Surgical oncology
  • Symmetrisation surgery, nipple reconstruction, lipo-modelling / fat transfer
  • Targeted axillary dissection after neo-adjuvant therapy
  • Therapeutic mammoplasty
  • Ultrasound, mammography, tomosynthesis, breast MRI, PET-CT
  • Wide local excision
  • Wireless localisation using savi scout radar and magseed technology

Professional memberships

Royal College of Surgeons of England
British Medical Association (BMA)
Association of Breast Surgery
General Medical Council

Articles by Mr Neill Patani

Sentinel lymph node micrometastasis in human breast cancer

Oncological and aesthetic considerations of skin-sparing mastectomy

Oncological safety and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction

The utility of MRI for the screening and staging of breast cancer

The clinical significance of sentinel lymph node micrometastasis in breast cancer

Osteopontin expression profiles predict pathological and clinical outcome in breast cancer

Prognostic utility of glycosyltransferase expression in breast cancer

The mRNA expression of SATB1 and SATB2 in human breast cancer

Oncological outcome and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction

Current management of DCIS

The utility of MRI for the screening and staging of breast cancer

Tumour suppressor function of MDA-7/IL-24 in human breast cancer

The impact of digital mammography on screening a young cohort of women for breast cancer in an urban specialist breast unit

High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer

Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer

Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer

Ductal carcinoma in-situ

The role of caveolin-1 in human breast cancer

Non-existence of caveolin-1 gene mutations in human breast cancer

Other specialists recommended by Mr Patani